UNIGE document Scientific Article
previous document  unige:99804  next document
add to browser collection
Title

Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?

Authors
Kletenkov, K
Hoffmann, D
Böni, J
Aubert, V
Schöni-Affolter, F
Struck, D
Verheyen, J
show hidden authors show all authors [1 - 9]
Published in Journal of Antimicrobial Chemotherapy. 2017, vol. 72, no. 3, p. 866-875
Abstract HIV Gag mutations have been reported to confer PI drug resistance. However, clinical implications are still controversial and most current genotyping algorithms consider solely the protease gene for assessing PI resistance.
Keywords Cohort StudiesDrug ResistanceViral/geneticsGenesGagGenotypeHIV Infections/blood/drug therapy/virologyHIV Protease/geneticsHIV Protease Inhibitors/pharmacology/therapeutic useHIV-1/drug effects/geneticsHumansMutationMissensePrevalenceRNAViral/bloodSequence AnalysisDNASwitzerlandTreatment FailureGag Gene ProductsHuman Immunodeficiency Virus/genetics
Identifiers
PMID: 27999036
Full text
Article (Published version) (714 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Laurent Kaiser (virologie clinique) (668)
Citation
(ISO format)
KLETENKOV, K et al. Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?. In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, n° 3, p. 866-875. https://archive-ouverte.unige.ch/unige:99804

11 hits

0 download

Update

Deposited on : 2017-11-29

Export document
Format :
Citation style :